In the past week, COSM stock has gone down by -2.71%, with a monthly gain of 79.54% and a quarterly surge of 99.21%. The volatility ratio for the week is 12.04%, and the volatility levels for the last 30 days are 19.06% for Cosmos Health Inc The simple moving average for the past 20 days is 23.50% for COSM’s stock, with a 34.67% simple moving average for the past 200 days.
Is It Worth Investing in Cosmos Health Inc (NASDAQ: COSM) Right Now?
COSM has 36-month beta value of 3.19. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for COSM is 15.38M, and currently, short sellers hold a 4.95% ratio of that float. The average trading volume of COSM on July 19, 2024 was 2.04M shares.
COSM) stock’s latest price update
Cosmos Health Inc (NASDAQ: COSM)’s stock price has decreased by -10.36 compared to its previous closing price of 1.40. However, the company has seen a -2.71% decrease in its stock price over the last five trading sessions. accesswire.com reported 2024-07-18 that CHICAGO, IL / ACCESSWIRE / July 18, 2024 / Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly-owned subsidiary, Cana Laboratories (‘Cana’), has secured additional contract manufacturing agreements with Provident Pharmaceuticals (‘Provident’), a specialty pharmaceutical company established in 2012 focused on commercializing and marketing niche and legacy pharmaceutical products, as well as medical devices in specific therapeutic areas. Specifically, Cana secured additional orders to manufacture the following medicines: 408,000 units of MIOREL, used to reduce and relieve excessive muscle spasms, commonly seen in conditions like multiple sclerosis, diseases, or spinal cord injuries; 222,000 units of CALCIFOLIN, an active metabolite of folic acid necessary for nucleic acid synthesis during cytotoxic therapy; 72,000 units of DEXA-DOSE, a synthetic glucocorticoid with potent anti-inflammatory properties, also used for its anti-allergic, anti-toxic, antipyretic, and immunosuppressive effects.
COSM Trading at 53.63% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.17% of loss for the given period.
Volatility was left at 19.06%, however, over the last 30 days, the volatility rate increased by 12.04%, as shares surge +70.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +85.51% upper at present.
During the last 5 trading sessions, COSM fell by -3.10%, which changed the moving average for the period of 200-days by -20.38% in comparison to the 20-day moving average, which settled at $1.0420. In addition, Cosmos Health Inc saw -10.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Siokas Grigorios, who purchase 60,000 shares at the price of $0.83 back on Feb 16 ’24. After this action, Siokas Grigorios now owns 1,394,597 shares of Cosmos Health Inc, valued at $49,806 using the latest closing price.
Siokas Grigorios, the Chief Executive Officer of Cosmos Health Inc, purchase 6,712 shares at $23.66 during a trade that took place back on Oct 12 ’23, which means that Siokas Grigorios is holding 1,334,597 shares at $158,806 based on the most recent closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.22 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.13. The total capital return value is set at -0.17. Equity return is now at value -64.96, with -26.64 for asset returns.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -1.54. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is -15.56.
Currently, EBITDA for the company is -9.47 million with net debt to EBITDA at -1.17. When we switch over and look at the enterprise to sales, we see a ratio of 0.79. The receivables turnover for the company is 1.28for trailing twelve months and the total asset turnover is 0.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.06.
Conclusion
To put it simply, Cosmos Health Inc (COSM) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
